Loading…
Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome
Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being devel...
Saved in:
Published in: | Balkan medical journal 2018-03, Vol.35 (2), p.163-166 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133 |
---|---|
cites | |
container_end_page | 166 |
container_issue | 2 |
container_start_page | 163 |
container_title | Balkan medical journal |
container_volume | 35 |
creator | Karaca, Emin Aykut, Ayça Ertürk, Biray Durmaz, Burak Güler, Ahmet Büke, Barış Yeniel, Ahmet Özgür Ergenoğlu, Ahmet Mete Özkınay, Ferda Özeren, Mehmet Kazandı, Mert Akercan, Fuat Sağol, Sermet Gündüz, Cumhur Çoğulu, Özgür |
description | Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions. |
doi_str_mv | 10.4274/balkanmedj.2017.0511 |
format | article |
fullrecord | <record><control><sourceid>doaj_cross</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4456d579588345c4992475c753234e0f</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4456d579588345c4992475c753234e0f</doaj_id><sourcerecordid>oai_doaj_org_article_4456d579588345c4992475c753234e0f</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133</originalsourceid><addsrcrecordid>eNpFkclOwzAQhiMEEhX0DTj4BVq8ZjlWLUulsqgFcbQmid26JHZlB5Xy9DgUgefgWexvNPMnyRXBY04zfl1C8w62VfV2TDHJxlgQcpIMKOHpiBFGTv98ys6TYQhbHE-KGWfFIPmaGVhbFzpToaVrFHIaPZjKu-XjBN187rwKwTiLnr3TJpaNRd1GxVBZ6KBBk9Ya13--bT5MjVbQ7hoVekp8srZgO_TmWmXR3nQbNHN7i1YHW_uYu0zONDRBDX_vi-T19uZlej9aPN3Np5PFqKI4JyNSkZxxXeaA61wAQFZmOI9WpgqzGldFykguCINKlzoOVnJNSUkLTXKuCGMXyfzIrR1s5c6bFvxBOjDyJ-H8WoKPIzRKci7SWmSFyGNLUfGioDwTVSYYZVxhHVn8yIobCsEr_ccjWPZyyH85ZC-H7OVg3_Ydf7I</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</title><source>PubMed Central Free</source><source>Publicly Available Content Database</source><creator>Karaca, Emin ; Aykut, Ayça ; Ertürk, Biray ; Durmaz, Burak ; Güler, Ahmet ; Büke, Barış ; Yeniel, Ahmet Özgür ; Ergenoğlu, Ahmet Mete ; Özkınay, Ferda ; Özeren, Mehmet ; Kazandı, Mert ; Akercan, Fuat ; Sağol, Sermet ; Gündüz, Cumhur ; Çoğulu, Özgür</creator><creatorcontrib>Karaca, Emin ; Aykut, Ayça ; Ertürk, Biray ; Durmaz, Burak ; Güler, Ahmet ; Büke, Barış ; Yeniel, Ahmet Özgür ; Ergenoğlu, Ahmet Mete ; Özkınay, Ferda ; Özeren, Mehmet ; Kazandı, Mert ; Akercan, Fuat ; Sağol, Sermet ; Gündüz, Cumhur ; Çoğulu, Özgür</creatorcontrib><description>Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.</description><identifier>ISSN: 2146-3123</identifier><identifier>EISSN: 2146-3131</identifier><identifier>DOI: 10.4274/balkanmedj.2017.0511</identifier><language>eng</language><publisher>Galenos Publishing House</publisher><subject>amniotic fluid ; Down syndrome ; microRNAs</subject><ispartof>Balkan medical journal, 2018-03, Vol.35 (2), p.163-166</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Karaca, Emin</creatorcontrib><creatorcontrib>Aykut, Ayça</creatorcontrib><creatorcontrib>Ertürk, Biray</creatorcontrib><creatorcontrib>Durmaz, Burak</creatorcontrib><creatorcontrib>Güler, Ahmet</creatorcontrib><creatorcontrib>Büke, Barış</creatorcontrib><creatorcontrib>Yeniel, Ahmet Özgür</creatorcontrib><creatorcontrib>Ergenoğlu, Ahmet Mete</creatorcontrib><creatorcontrib>Özkınay, Ferda</creatorcontrib><creatorcontrib>Özeren, Mehmet</creatorcontrib><creatorcontrib>Kazandı, Mert</creatorcontrib><creatorcontrib>Akercan, Fuat</creatorcontrib><creatorcontrib>Sağol, Sermet</creatorcontrib><creatorcontrib>Gündüz, Cumhur</creatorcontrib><creatorcontrib>Çoğulu, Özgür</creatorcontrib><title>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</title><title>Balkan medical journal</title><description>Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.</description><subject>amniotic fluid</subject><subject>Down syndrome</subject><subject>microRNAs</subject><issn>2146-3123</issn><issn>2146-3131</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpFkclOwzAQhiMEEhX0DTj4BVq8ZjlWLUulsqgFcbQmid26JHZlB5Xy9DgUgefgWexvNPMnyRXBY04zfl1C8w62VfV2TDHJxlgQcpIMKOHpiBFGTv98ys6TYQhbHE-KGWfFIPmaGVhbFzpToaVrFHIaPZjKu-XjBN187rwKwTiLnr3TJpaNRd1GxVBZ6KBBk9Ya13--bT5MjVbQ7hoVekp8srZgO_TmWmXR3nQbNHN7i1YHW_uYu0zONDRBDX_vi-T19uZlej9aPN3Np5PFqKI4JyNSkZxxXeaA61wAQFZmOI9WpgqzGldFykguCINKlzoOVnJNSUkLTXKuCGMXyfzIrR1s5c6bFvxBOjDyJ-H8WoKPIzRKci7SWmSFyGNLUfGioDwTVSYYZVxhHVn8yIobCsEr_ccjWPZyyH85ZC-H7OVg3_Ydf7I</recordid><startdate>20180315</startdate><enddate>20180315</enddate><creator>Karaca, Emin</creator><creator>Aykut, Ayça</creator><creator>Ertürk, Biray</creator><creator>Durmaz, Burak</creator><creator>Güler, Ahmet</creator><creator>Büke, Barış</creator><creator>Yeniel, Ahmet Özgür</creator><creator>Ergenoğlu, Ahmet Mete</creator><creator>Özkınay, Ferda</creator><creator>Özeren, Mehmet</creator><creator>Kazandı, Mert</creator><creator>Akercan, Fuat</creator><creator>Sağol, Sermet</creator><creator>Gündüz, Cumhur</creator><creator>Çoğulu, Özgür</creator><general>Galenos Publishing House</general><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>20180315</creationdate><title>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</title><author>Karaca, Emin ; Aykut, Ayça ; Ertürk, Biray ; Durmaz, Burak ; Güler, Ahmet ; Büke, Barış ; Yeniel, Ahmet Özgür ; Ergenoğlu, Ahmet Mete ; Özkınay, Ferda ; Özeren, Mehmet ; Kazandı, Mert ; Akercan, Fuat ; Sağol, Sermet ; Gündüz, Cumhur ; Çoğulu, Özgür</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>amniotic fluid</topic><topic>Down syndrome</topic><topic>microRNAs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Karaca, Emin</creatorcontrib><creatorcontrib>Aykut, Ayça</creatorcontrib><creatorcontrib>Ertürk, Biray</creatorcontrib><creatorcontrib>Durmaz, Burak</creatorcontrib><creatorcontrib>Güler, Ahmet</creatorcontrib><creatorcontrib>Büke, Barış</creatorcontrib><creatorcontrib>Yeniel, Ahmet Özgür</creatorcontrib><creatorcontrib>Ergenoğlu, Ahmet Mete</creatorcontrib><creatorcontrib>Özkınay, Ferda</creatorcontrib><creatorcontrib>Özeren, Mehmet</creatorcontrib><creatorcontrib>Kazandı, Mert</creatorcontrib><creatorcontrib>Akercan, Fuat</creatorcontrib><creatorcontrib>Sağol, Sermet</creatorcontrib><creatorcontrib>Gündüz, Cumhur</creatorcontrib><creatorcontrib>Çoğulu, Özgür</creatorcontrib><collection>CrossRef</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Balkan medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Karaca, Emin</au><au>Aykut, Ayça</au><au>Ertürk, Biray</au><au>Durmaz, Burak</au><au>Güler, Ahmet</au><au>Büke, Barış</au><au>Yeniel, Ahmet Özgür</au><au>Ergenoğlu, Ahmet Mete</au><au>Özkınay, Ferda</au><au>Özeren, Mehmet</au><au>Kazandı, Mert</au><au>Akercan, Fuat</au><au>Sağol, Sermet</au><au>Gündüz, Cumhur</au><au>Çoğulu, Özgür</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome</atitle><jtitle>Balkan medical journal</jtitle><date>2018-03-15</date><risdate>2018</risdate><volume>35</volume><issue>2</issue><spage>163</spage><epage>166</epage><pages>163-166</pages><issn>2146-3123</issn><eissn>2146-3131</eissn><abstract>Background: Down syndrome, which is the most common human chromosomal anomaly that can affect people of any race and age, can be diagnosed prenatally in most cases. Prenatal diagnosis via culture method is time-consuming; thus, genetic analysis has thus been introduced and is continually being developed for rapid prenatal diagnosis. For this reason, the effective use of microRNA profiling for the rapid analysis of prenatal amniotic fluid samples for the diagnosis of Down syndrome was investigated. Aims: To evaluate the expression levels of 14 microRNAs encoded by chromosome 21 in amniotic fluid samples and their utility for prenatal diagnosis of Down syndrome. Study Design: Case-control study. Methods: We performed invasive prenatal testing for 56 pregnant women; 23 carried fetuses with Down syndrome, and 33 carried fetuses with a normal karyotype. Advanced maternal age and increased risk for Down syndrome in the screening tests were indications for invasive prenatal testing. The age of gestation in the study and control groups ranged between 17 and 18 weeks. The expression levels of microRNA were measured by real-time polymerase chain reaction. Results: The expression levels of microRNA-125b-2, microRNA-155, and microRNA-3156 were significantly higher in the study group than in the control group. Conclusion: The presence of significantly dysregulated microRNAs may be associated with either the phenotype or the result of abnormal development. Further large-scale comparative studies conducted in a variety of conditions may bring novel insights in the field of abnormal prenatal conditions.</abstract><pub>Galenos Publishing House</pub><doi>10.4274/balkanmedj.2017.0511</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2146-3123 |
ispartof | Balkan medical journal, 2018-03, Vol.35 (2), p.163-166 |
issn | 2146-3123 2146-3131 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_4456d579588345c4992475c753234e0f |
source | PubMed Central Free; Publicly Available Content Database |
subjects | amniotic fluid Down syndrome microRNAs |
title | Diagnostic Role of MicroRNA Expression Profile in the Prenatal Amniotic Fluid Samples of Pregnant Women with Down Syndrome |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A33%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20Role%20of%20MicroRNA%20Expression%20Profile%20in%20the%20Prenatal%20Amniotic%20Fluid%20Samples%20of%20Pregnant%20Women%20with%20Down%20Syndrome&rft.jtitle=Balkan%20medical%20journal&rft.au=Karaca,%20Emin&rft.date=2018-03-15&rft.volume=35&rft.issue=2&rft.spage=163&rft.epage=166&rft.pages=163-166&rft.issn=2146-3123&rft.eissn=2146-3131&rft_id=info:doi/10.4274/balkanmedj.2017.0511&rft_dat=%3Cdoaj_cross%3Eoai_doaj_org_article_4456d579588345c4992475c753234e0f%3C/doaj_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2081-1c1834fb8a0d85aaa7b708080b6e03d0c96318513acfbf060b4f21b29f184e133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |